Skip to content

In the BioHarmony Drug Report Database

Pixantrone dimaleate

Pixuvri (pixantrone dimaleate) is a small molecule pharmaceutical. Pixantrone dimaleate was first approved as Pixuvri on 2012-05-10. It has been approved in Europe to treat non-hodgkin lymphoma.
Trade Name Pixuvri
Common Name Pixantrone dimaleate
Indication non-hodgkin lymphoma
Drug Class Antineoplastics, anthraquinone derivatives
Pixantrone dimaleate
Get full access now